Clinical Trial Update: A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating the safety and tolerability of AZD1390 in combination with radiation therapy for brain cancer, including primary and recurrent gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Leptomeningeal Disease
• Malignant Brain Neoplasms

Drugs mentioned

• AZD1390

Snippet

Sponsor: AstraZeneca | Conditions: Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme | Phase 1 | Status: RECRUITING